Named the XT250 System, its underlying technology was originally developed to protect the public from terrorist threats, but has since found its role in the pharmaceutical industry. It can tell if a drug is counterfeit, altered, contaminated, or otherwise different on a molecular level from its intended form.
“This unit is of great benefit when dealing with drugs or ingredients from questionable sources, such as what we’ve seen from China in the recent Heparin incident,” stated John Lundquist, VP of Business Development for XStream Systems. “The fact it can test drugs when they are still in the manufacturer’
The XT250 System is currently being used at multiple locations in the pharmaceutical supply network, checking inventories for dangerous products.
